Business Description
Malaysian Genomics Resource Centre Bhd
ISIN : MYQ0155OO000
Total Employee Number:
35Description
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.94 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 1.21 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 9.48 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 50.5 | |||||
3-Year EBITDA Growth Rate | 41 | |||||
3-Year EPS without NRI Growth Rate | 41.5 | |||||
3-Year Book Growth Rate | -8.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 90.31 | |||||
9-Day RSI | 78 | |||||
14-Day RSI | 71.59 | |||||
3-1 Month Momentum % | 38.46 | |||||
6-1 Month Momentum % | 35 | |||||
12-1 Month Momentum % | 35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.53 | |||||
Quick Ratio | 5.26 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 87.1 | |||||
Days Sales Outstanding | 302.56 | |||||
Days Payable | 295.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -4.59 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.3 | |||||
Operating Margin % | -5.78 | |||||
Net Margin % | -5.3 | |||||
EBITDA Margin % | 10.17 | |||||
FCF Margin % | 10.21 | |||||
OCF Margin % | 10.27 | |||||
ROE % | -2.84 | |||||
ROA % | -2.4 | |||||
ROIC % | -3.15 | |||||
3-Year ROIIC % | 163.27 | |||||
ROC (Joel Greenblatt) % | -4.59 | |||||
ROCE % | -2.79 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 3.28 | |||||
Shiller PE Ratio | 48.67 | |||||
PS Ratio | 4.47 | |||||
PB Ratio | 2.3 | |||||
Price-to-Tangible-Book | 2.78 | |||||
Price-to-Free-Cash-Flow | 42.14 | |||||
Price-to-Operating-Cash-Flow | 42.14 | |||||
EV-to-EBIT | -84.34 | |||||
EV-to-EBITDA | 43.46 | |||||
EV-to-Forward-EBITDA | 7.61 | |||||
EV-to-Revenue | 4.42 | |||||
EV-to-Forward-Revenue | 3.05 | |||||
EV-to-FCF | 43.32 | |||||
Price-to-GF-Value | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 4.22 | |||||
| Price-to-Net-Cash | 29.5 | |||||
Earnings Yield (Greenblatt) % | -1.19 | |||||
FCF Yield % | 2.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Malaysian Genomics Resource Centre Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 9.328 | ||
| EPS (TTM) (RM) | -0.004 | ||
| Beta | 0.587 | ||
| 3-Year Sharpe Ratio | -0.68 | ||
| 3-Year Sortino Ratio | -0.91 | ||
| Volatility % | 39.59 | ||
| 14-Day RSI | 71.59 | ||
| 14-Day ATR (RM) | 0.004516 | ||
| 20-Day SMA (RM) | 0.27775 | ||
| 12-1 Month Momentum % | 35 | ||
| 52-Week Range (RM) | 0.155 - 0.3 | ||
| Shares Outstanding (Mil) | 150.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Malaysian Genomics Resource Centre Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Malaysian Genomics Resource Centre Bhd Stock Events
| Event | Date | Price (RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Malaysian Genomics Resource Centre Bhd Frequently Asked Questions
What is Malaysian Genomics Resource Centre Bhd(XKLS:0155)'s stock price today?
The current price of XKLS:0155 is RM0.30. The 52 week high of XKLS:0155 is RM0.30 and 52 week low is RM0.16.
When is next earnings date of Malaysian Genomics Resource Centre Bhd(XKLS:0155)?
The next earnings date of Malaysian Genomics Resource Centre Bhd(XKLS:0155) is .
Does Malaysian Genomics Resource Centre Bhd(XKLS:0155) pay dividends? If so, how much?
Malaysian Genomics Resource Centre Bhd(XKLS:0155) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Malaysian Genomics Resource Centre Bhd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers